Cost-effectiveness of an invasive strategy in unstable coronary artery disease: results from the FRISC II invasive trial

Authors
Category Primary study
Year 2002
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. When assessed after 12 months, the invasive treatment (IT) had resulted in fewer deaths and fewer myocardial infarctions (MIs), but was more expensive than the non-invasive treatment (NIT).
Epistemonikos ID: 87aac1b1e3716e85c6088085f5234c2a7f2374a8
First added on: Apr 19, 2023